Modular protein engineering for non-viral gene therapy.

Area of Science:

• Biotechnology
• Gene Therapy
• Molecular Engineering

Background:

• Viral vectors are widely used for gene therapy but raise safety concerns.
• Non-viral vectors are sought as safer alternatives for nucleic acid delivery.
• Recombinant proteins offer a promising platform for bioproduction of gene delivery vehicles.

Purpose of the Study:

• To engineer novel non-viral gene delivery vectors using modular recombinant proteins.
• To mimic essential viral vector functions for efficient gene delivery.
• To develop safe and effective alternatives to viral vectors for gene therapy.

Main Methods:

• Modular engineering of chimeric polypeptides with selected functional domains.
• Bioproduction of recombinant proteins for large-scale vector generation.
• In vitro and in vivo testing of gene delivery efficiency and specificity.

Main Results:

• Developed promising protein-based prototypes capable of delivering expressible DNA.
• Demonstrated successful gene delivery to tissue culture and specific cell types in vivo.
• Achieved essential gene delivery functions including nucleic acid condensation, cell internalization, and endosomal escape.

Conclusions:

• Engineered recombinant proteins represent a viable and safer alternative to viral vectors for gene therapy.
• Modular protein design allows for the creation of versatile gene delivery systems.
• These novel vectors show potential for therapeutic applications in various organisms.